PCSK9抑制剂对心脑血管疾病的性作用

相关实验视频

Updated: Jun 3, 2025

08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.1K

Zhenzhen Li¹, Lin Zhu¹, Yeqiong Xu²

¹Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.

Biomedicines

|January 8, 2025

概括

PCSK9抑制剂,结合他类药物,有效降低低密度脂蛋白胆固醇 (LDL-C) 在心血管疾病 (CVD) 和症状内动脉狭窄 (sICAS) 的患者. 这些抑制剂除了降低LDL-C之外还提供了额外的好处,改善了患者的治疗结果.

科学领域:

心血管医学心血管医学
神经学神经学
药理学药理学是指药理学的学科.

背景情况:

心血管疾病 (CVD) 和缺血性中风 (IS) 是全球主要的死亡原因.
高胆固醇血症是心血管疾病和IS的重要独立风险因素.
降低低密度脂蛋白胆固醇 (LDL-C) 对于减轻血管事件和改善预后至关重要.

研究的目的:

审查9型 (PCSK9) 抑制剂的蛋白转化酶亚素-素抑制剂的性作用.
专注于PCSK9抑制剂对心血管和中枢神经系统的影响.
探索PCSK9抑制剂在管理高脂血症和相关血管疾病方面的不断发展的理解.

主要方法:

随机对照试验 (RCT) 和相关研究的综合文献综述.
分析PCSK9抑制剂在降低LDL-C水平中的作用机制.
对支持PCSK9抑制剂与他类药物联合使用的临床证据的评估.

主要成果:

PCSK9抑制剂通过增强LDL受体 (LDLR) 循环和吸收,显著降低LDL-C水平.
使用PCSK9抑制剂和他类药物的联合治疗改善了心血管疾病和症状内动脉狭窄症 (sICAS) 患者的预后.
PCSK9抑制剂表现出性作用,包括抗炎,抗动脉样硬化,斑块稳定和抗血栓性质.

结论:

PCSK9抑制剂是高脂血症的有价值的治疗选择,特别是对于那些不对单独使用他类药物反应的高风险患者.
除了降低LDL-C,PCSK9抑制剂还提供多方面的好处,影响心血管和神经健康.
进一步研究PCSK9抑制剂全谱变性可能会揭示扩大治疗应用.

关键词:

动脉样硬化动脉样硬化心血管系统的心血管系统中枢神经系统中枢神经系统这是一种炎症炎症炎症炎症.脂质新陈代谢脂质新陈代谢血小板血小板血小板是什么?热的效应热的效应蛋白转化酶亚提利辛-凯类型9

相关概念视频

01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

135

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

135

01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

465

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

465

01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

381

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

381

01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.0K

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...